Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  WT-1 analogue peptide vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-4 of 4 for your search:
Start Over
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 to 74
Sponsor: NCI
Protocol IDs: 080051, 08-C-0051, NCT00923910
Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 85
Sponsor: NHLBI
Protocol IDs: 070091, 07-H-0091, NHLBI-07-H-0091, NCT00433745
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06-085, P30CA008748, P01CA023766, MSKCC-06085, NCT00398138
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-15025, INNO-305 WT-1, 105946, NCT00665002
Start Over